Federal Judge Holds High-Stakes Hearings Today on Five Drug Industry 340B Rebate Lawsuits

U.S. District Judge Dabney Friedrich of the District of Columbia is presiding over five April 29 hearings over drugmaker 340B rebate lawsuits. She previously largely sided with Novartis and United Therapeutics in a separate case on drugmaker contract pharmacy restrictions.
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audits Find Two Drugmakers Overcharged for 340B Drugs, Driving Calls for More Drug Industry Oversight 

HRSA released the results of its first two drugmaker audits of 2025 this month.
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California, Texas, Oklahoma Advance 340B Contract Pharmacy Access Bills with Key Amendments

California lawmakers recently advanced a 340B contract pharmacy access bill through committee but amended it to exclude 340B hospitals.
State legislators in California, Texas and Oklahoma have recently advanced 340B contract pharmacy access bills with amendments that in some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Remained Strong in Early 2025, Filings Show

Just over 300 firms listed the 340B program in their first quarter lobbying disclosure forms that were due April 21.
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Appellate Court Briefings on 340B Laws in West Virginia, Louisiana

Key briefs were filed recently in state contract pharmacy litigation in two federal appeals court.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Trump Pharmaceutical Tariffs Loom, Drug Industry Pledges Investment in U.S. Manufacturing, Warns of Disruptions 

A recent survey of biotechnology firms reported that Trump's planned pharmaceutical tariffs would set back scientific innovation and reduce patients' access to medications.
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Continues to Oppose Unapproved Drugmaker 340B Rebate Models in New Legal Filings

HHS has again urged a federal district court to reject multiple drug industry lawsuits seeking to implement 340B rebate models.
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Sues Utah Over New 340B Contract Pharmacy Access Law

A drug industry trade group recently challenged Utah's new 340B contract pharmacy access law in the U.S. District Court for the District of Utah.
An influential drug industry trade group on Friday sued Utah over its 340B contract pharmacy access law, marking the third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live